Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma

NEXT STORY
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE “TRANSPARENCY LAW”)
PREV STORY
ABLYNX COMPLETES PATIENT RECRUITMENT IN THE PHASE IIb RESPIRE STUDY OF ITS INHALED ANTI-RSV NANOBODY ALX-0171
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

SHIRE RELEASES DATA AT THE WFH CONGRESS 2018 EVALUATING VONVENDI® IN ADULTS WITH VON WILLEBRAND DISEASE DURING AND AFTER SURGERY

P SHIRE RELEASES DATA AT THE WORLD FEDERATION OF HEMOPHILIA CONGRESS 2018 EVALUATING VONVENDI® ...

author_avatar
NASDAQ Market News

Elite Pharmaceuticals Launches Generic Methadone Tablets

NORTHVALE, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the ...

author_avatar
NASDAQ Market News

REPEAT – QUESTCAP TO INVEST $1 MILLION WITH SUNNYBROOK RESEARCH INSTITUTE TO ESTABLISH THE SUNNYBROOK TRANSLATIONAL RESEARCH GROUP FOR EMERGING AND RESPIRATORY VIRUSES

author_avatar
NASDAQ Market News